| ID | 60490 | 
| FullText URL | |
| Author | 
                Akashi, Sho
                  Department of Biochemistry and Molecular Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
     
                    Nishida, Takashi
                Department of Biochemistry and Molecular Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
                    Kaken ID 
                    publons 
                    researchmap 
     
                Mizukawa, Tomomi
                Department of Biochemistry and Molecular Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
     
                Kawata, Kazumi
                Department of Biochemistry and Molecular Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
     
                    Takigawa, Masaharu
                Department of Oral and Maxillofacial Reconstructive Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
                    Kaken ID 
                    publons 
                    researchmap 
     
                    Iida, Seiji
                  Department of Oral and Maxillofacial Reconstructive Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
                    Kaken ID 
                    publons 
                    researchmap 
     
                    Kubota, Satoshi
                Department of Biochemistry and Molecular Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
                    Kaken ID 
                    publons 
                    researchmap 
     | 
| Abstract | Objectives: Anti-osteoclastic treatments for breast cancer occasionally cause medication-related osteonecrosis of the jaw. Moreover, elevated glycolytic activity, which is known as the Warburg effect, is usually observed in these breast cancer cells. Previously, we found that cellular communication network factor 2 (CCN2) production and glycolysis enhanced each other in chondrocytes. Here, we evaluated the interplay between CCN2 and glycolysis in breast cancer cells, as we suspected a possible involvement of CCN2 in the Warburg effect in highly invasive breast cancer cells.  Methods: Two human breast cancer cell lines with a distinct phenotype were used. Glycolysis was inhibited by using 2 distinct compounds, and gene silencing was performed using siRNA. Glycolysis and the expression of relevant genes were monitored via colorimetric assays and quantitative RT-PCR, respectively. Results: Although CCN2 expression was almost completely silenced when treating invasive breast cancer cells with a siRNA cocktail against CCN2, glycolytic activity was not affected. Notably, the expression of glycolytic enzyme genes, which was repressed by CCN2 deficiency in chondrocytes, tended to increase upon CCN2 silencing in breast cancer cells. Inhibition of glycolysis, which resulted in the repression of CCN2 expression in chondrocytic cells, did not alter or strongly enhanced CCN2 expression in the invasive and non-invasive breast cancer cells, respectively. Conclusions: High CCN2 expression levels play a critical role in the invasion and metastasis of breast cancer. Thus, a collapse in the intrinsic repressive machinery of CCN2 due to glycolysis may induce the acquisition of an invasive phenotype in breast cancer cells. | 
| Keywords | Bone metastasis Breast cancer CCN2 Glycolysis Warburg effect | 
| Note | This is an Accepted Manuscript of an article published by Elsevier © 2020 Japanese Association for Oral Biology. This manuscript version is made available under the CC-BY-NC-ND 4.0 License.http://creativecommons.org/licenses/by-nc-nd/4.0/.This is the accepted manuscript version. The formal published version is available at [https://doi.org/10.1016/j.job.2020.07.001] . | 
| Published Date | 2020-08-11 | 
| Publication Title | 
            Journal of Oral Biosciences
     | 
| Volume | volume62 | 
| Issue | issue3 | 
| Publisher | Elsevier | 
| Start Page | 280 | 
| End Page | 288 | 
| ISSN | 13490079 | 
| NCID | AA11896386 | 
| Content Type | 
            Journal Article
     | 
| language | 
            English
     | 
| OAI-PMH Set | 
            岡山大学
     | 
| File Version | author | 
| PubMed ID | |
| DOI | |
| Web of Science KeyUT | |
| Related Url | isVersionOf https://doi.org/10.1016/j.job.2020.07.001 | 
| License | http://creativecommons.org/licenses/by-nc-nd/4.0/ | 
| Citation | Akashi S, Nishida T, Mizukawa T, Kawata K, Takigawa M, Iida S, Kubota S. Regulation of cellular communication network factor 2 (CCN2) in breast cancer cells via the cell-type dependent interplay between CCN2 and glycolysis. J Oral Biosci. 2020 Sep;62(3):280-288. doi: 10.1016/j.job.2020.07.001. Epub 2020 Aug 11. PMID: 32791309. | 
| Funder Name | 
            Japan Society for the Promotion of Science
     | 
| 助成番号 | 17K19756 17K19757 19H03817 19K22716 | 
| Open Access (Publisher) | 
            non-OA
     | 
| Open Archive (publisher) | 
            Non-OpenArchive
     |